SCHEMBL1701097

SCHEMBL1701097

COc1cnc(-c2ccccn2)nc1NC(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 11/20 1.00
L3MBTL1 Q9Y468 8/20 1.00
SMN1; SMN2 Q16637 7/20 1.00
LMNA P02545 5/20 1.00
MAPT P10636 3/20 1.00
MITF O75030 1/20 1.00
KDM4E B2RXH2 2/20 0.58
HTT P42858 2/20 0.58
ALDH1A1 P00352 4/20 0.54
MEN1 O00255 3/20 0.54
PPP1CA P62136 3/20 0.54
KMT2A Q03164 3/20 0.54
TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29968698 1.00 TRPM8 (1.00) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Fumaric Acid SCHEMBL1701484 0.91 TRPM8 (0.82) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Fumaric Acid SCHEMBL13277766 0.91 TRPM8 (0.82) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Fumaric Acid SCHEMBL13277769 0.91 TRPM8 (0.82) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Fumaric Acid SCHEMBL13277768 0.91 TRPM8 (0.82) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Succinic Acid SCHEMBL13277748 0.90 TRPM8 (0.80) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Succinic Acid SCHEMBL1701275 0.90 TRPM8 (0.80) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Cadaverine Tartrate SCHEMBL1701294 0.90 TRPM8 (0.80) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
Cadaverine Tartrate SCHEMBL13277601 0.90 TRPM8 (0.80) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT
SCHEMBL1699152 0.90 TRPM8 (1.00) TRPM8L3MBTL1SMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
EP-4725476-A2 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF Firmenich SA (CH) 2026-04-15 EP disclosed
EP-4096714-B1 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF FIRMENICH & CIE (CH) 2026-01-28 EP disclosed
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-12-25 US disclosed
EP-4608518-A1 ORAL CARE COMPOSITIONS Firmenich SA (CH) 2025-09-03 EP disclosed
EP-4251122-B1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-03-12 EP disclosed
US-20250064063-A1 ANTIMICROBIAL COMPOSITION HAVING ENCAPSULATED COLORANT FIRMENICH SA (CH) 2025-02-27 US disclosed
EP-3663366-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2025-01-08 EP disclosed
US-20240307279-A1 FAST DRYING PERFUME COMPOSITION FIRMENICH SA (CH) 2024-09-19 US disclosed
US-20240285512-A1 ORAL CARE COMPOSITIONS FIRMENICH SA (CH) 2024-08-29 US disclosed
US-20120202806-A1 Novel Pyrimidine- And Triazine-Hepcidine Antagonists VIFOR (INTERNATIONAL) AG (CH) 2012-08-09 US disclosed
WO-2011061330-A9 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2012-01-05 WO disclosed
WO-2011061330-A9 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2012-01-05 WO disclosed
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2011-06-23 US disclosed
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2011-06-23 US disclosed
WO-2011061330-A2 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2011-05-26 WO disclosed
WO-2011061330-A2 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2011-05-26 WO disclosed
WO-2011026835-A1 NOVEL PYRIMIDINE AND TRIAZINE HEPCIDINE ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-10 WO disclosed
WO-2010149798-A2 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT SYMRISE AG (DE) 2010-12-29 WO disclosed
WO-2010026094-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 TRPM8 1/4885L3MBTL1 3284/4885SMN1; SMN2 2480/4885
US-20120202806-A1 Novel Pyrimidine- And Triazine-Hepcidine Antagonists HAMP, DHPS, SLC40A1 TRPM8 2345/4885L3MBTL1 3829/4885SMN1; SMN2 4562/4885
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT TAS2R30, TAS2R1, TAS2R20 TRPM8 165/4885L3MBTL1 3320/4885SMN1; SMN2 651/4885
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 TRPM8, TRPM2, TRPM7 TRPM8 1/4885L3MBTL1 3676/4885SMN1; SMN2 4627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.